First Horizon Advisors, Inc. Oramed Pharmaceuticals Inc. Transaction History
First Horizon Advisors, Inc.
- $3.53 Billion
- Q1 2025
A detailed history of First Horizon Advisors, Inc. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,750 shares of ORMP stock, worth $3,954. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,750Holding current value
$3,954% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORMP
# of Institutions
62Shares Held
8.07MCall Options Held
17.4KPut Options Held
19.5K-
Bml Capital Management, LLC Zionsville, IN3.02MShares$6.83 Million5.23% of portfolio
-
Murchinson Ltd. Toronto, A61.75MShares$3.96 Million2.03% of portfolio
-
Boothbay Fund Management, LLC New York, NY845KShares$1.91 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$828,0662.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$654,9540.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $87.7M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...